ANDA 76528, held by Able. Acetaminophen; Butalbital; Caffeine; Codeine Phosphate, Butalbital; Acetaminophen; Caffeine; Codeine Phosphate.
As of Nov 16, 2026, ANDA 76528 (Butalbital, Acetaminophen, Caffeine And Codeine Phosphate, Butalbital; Acetaminophen; Caffeine; Codeine), held by Able, was first approved by FDA on Aug 21, 2003, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 21, 2003 | Original application | Approved | None posted |
| Butalbital, Acetaminophen, Caffeine And Codeine Phosphate325MG;50MG;40MG;30MG · capsule;oral | Acetaminophen; Butalbital; Caffeine; Codeine Phosphate | Discontinued |
| Butalbital; Acetaminophen; Caffeine; Codeine40MG/30MG · capsule; oral | Butalbital; Acetaminophen; Caffeine; Codeine Phosphate | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters